Systemic sarcoidosis induced by etanercept: first Brazilian case report

Abstract

The antagonists of tumor necrosis factor alpha (TNF-α) are increasingly being used in the treatment of inflammatory and autoimmune diseases. Several adverse effects of these drugs have been reported, including the paradoxical development of sarcoidosis, especially with the use of etanercept. We present the first Brazilian case report of systemic sarcoidosis induced by etanercept and a literature review.

Keywords

• Diagnosis
• Granuloma
• Sarcoidosis
• Tumor necrosis factor-alpha